Development of a novel serological assay for the detection of mpox infection in vaccinated populations
Journal of Medical Virology · 2023-10 · 95 (10)
DOI: 10.1002/jmv.29134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 08.10.2023. Verfasst von Jennifer L Yates und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Orthopoxvirus. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
In 2022 the World Health Organization declared a Public Health Emergency for an outbreak of mpox, the zoonotic Orthopoxvirus (OPV) affecting at least 104 nonendemic locations worldwide. Serologic detection of mpox infection is problematic, however, due to considerable antigenic and serologic cross‐reactivity among OPVs and smallpox‐vaccinated individuals. In this report, we developed a high‐throughput multiplex microsphere immunoassay using a combination of mpox‐specific peptides and cross‐reactive OPV proteins that results in the specific serologic detection of mpox infection with 93% sensitivity and 98% specificity. The New York State Non‐Vaccinia Orthopoxvirus Microsphere Immunoassay is an important tool to detect subclinical mpox infection and understand the extent of mpox spread in the community through retrospective analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
- Department of Biomedical Sciences, The School of Public Heath, The University at Albany, Albany, New York, USA.
- Scientific Cores, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
- Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, USA.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
ORCID-Profile: Jennifer L Yates, Deena Altman
Förderung
- CDC HHS
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Yates, J. L., Hunt, D. T., Kulas, K. E., Chave, K. J., Styer, L., Chakravarthi, S. T., Cai, G. Y., Bermúdez-González, M. C., Kleiner, G., Altman, D., Srivastava, K., PVI Study Group, Simon, V., Feihel, D., McGowan, J., Hogrefe, W., Noone, P., Egan, C., Slifka, M. K., & Lee, W. T. (2023). Development of a novel serological assay for the detection of mpox infection in vaccinated populations. Journal of Medical Virology, 95(10). https://doi.org/10.1002/jmv.29134
Vancouver
Yates JL, Hunt DT, Kulas KE, Chave KJ, Styer L, Chakravarthi ST, et al. Development of a novel serological assay for the detection of mpox infection in vaccinated populations. Journal of Medical Virology. 2023;95(10). doi:10.1002/jmv.29134
BibTeX
@article{Yates2023,
author = {Yates, Jennifer L and Hunt, Danielle T and Kulas, Karen E and Chave, Karen J and Styer, Linda and Chakravarthi, Sandhya T and Cai, Gianna Y and Bermúdez-González, Maria C and Kleiner, Giulio and Altman, Deena and Srivastava, Komal and PVI Study Group, PVI Study Group and Simon, Viviana and Feihel, Dennis and McGowan, Joseph and Hogrefe, Wayne and Noone, Philip and Egan, Christina and Slifka, Mark K and Lee, William T},
title = {Development of a novel serological assay for the detection of mpox infection in vaccinated populations},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {10},
doi = {10.1002/jmv.29134}
}
EUVIMED